Introducing the CKMB Biochemistry Reagent Labkit, a comprehensive diagnostic solution designed for the accurate measurement of Creatine Kinase MB (CK-MB) in patient serum or plasma samples. CK-MB is a cardiac-specific biomarker widely used in the diagnosis and monitoring of acute myocardial infarction (heart attack) and other cardiac conditions. Our Labkit offers a reliable and efficient method for assessing CK-MB levels, aiding in the timely detection and management of cardiac disorders.

The CKMB Biochemistry Reagent – Labkit utilizes specially formulated reagents and materials optimized for accurate and consistent testing results. By combining the Labkit reagent with patient samples, the CK-MB present in the samples reacts with the reagent, resulting in a measurable response. This quantitative measurement provides valuable information about the extent of cardiac damage and helps healthcare professionals make informed decisions regarding patient care.

Our Labkit is designed with ease of use in mind, providing clear instructions that guide laboratory technicians through the testing process. Rigorous quality control measures are implemented during the manufacturing process to ensure the reliability and accuracy of diagnostic outcomes.

By utilizing the CKMB Biochemistry Reagent – Labkit, healthcare providers can quickly and effectively assess CK-MB levels, enabling early detection of cardiac disorders and facilitating prompt intervention. Regular monitoring of CK-MB levels using our Labkit allows for ongoing evaluation of treatment efficacy and the overall management of cardiac health.

Trust in the performance and accuracy of the CKMB Biochemistry Reagent – Labkit to enhance your laboratory’s diagnostic capabilities. Whether you operate a small clinic or a large healthcare facility, our Labkit offers a reliable solution for CK-MB testing. Elevate your patient care standards and contribute to the effective management of cardiac disorders with our advanced Labkit.

Invest in the CKMB Biochemistry Reagent – Labkit today and equip your laboratory with the necessary tools to accurately assess CK-MB levels. Ensure timely diagnosis, personalized treatment, and improved patient outcomes with our high-quality Labkit. Contact us now to order your CKMB Biochemistry Reagent – Labkit and join healthcare professionals worldwide in utilizing this essential diagnostic solution.

Creatine kinase (CK) is a cytosolic carrier protein for high-energy phosphates.CK-MB is an isoenzyme of CK that is most abundant in the heart. However, CK-MB also constitutes 1% to 3% of the CK in skeletal muscle and is present in a small fraction in other organs, such as the small bowel, uterus, prostate, and diaphragm. Among the first biomarkers applied in clinical routine for the detection of myocardial necrosis were creatine kinase myocardial band (CK-MB) and myoglobin. Due to a rather slow dynamic change, CK-MB is of secondary importance for acute decision-making. However, an increase of CK-MB remains an important biomarker for patients with diagnosed AMI.

Furthermore, current ESC guidelines recommend CK-MB as the preferred biomarker for patients who present early after prior AMI,  as the rapid decline of CK-MB to the reference interval by 48 to 72 hours allows for the discrimination of early re-infarction when symptoms recur between 72 hours and 2 weeks after the index acute MI, when troponin may still be elevated.

Buy Best Biochemistry Analyzer From Medistore